Both central and peripheral tolerance mechanisms play roles in diabetes prevention in NOD-E transgenic mice

References

• Adorini L, Gregori S, Harrison LC. Understanding autoimmune diabetes: Insights from mouse models. Trends Mol Med 2002; 8: 31–38
   PubMed Web of Science ®Google Scholar
• Uno M, Miyazaki T, Uehira M, Nishimoto H, Kimoto M, Miyazaki J, Yamamura K. Complete prevention of diabetes in transgenic NOD mice expressing I-E molecules. Immunol Lett 1992; 31: 47–52
   PubMed Web of Science ®Google Scholar
• Nishimoto H, Kikutani H, Yamamura K, Kishimoto T. Prevention of autoimmune insulitis by expression of I-E molecules in NOD mice. Nature 1987; 328: 432–434
   PubMed Web of Science ®Google Scholar
• Lund T, O'Reilly L, Hutchings P, Kanagawa O, Simpson E, Gravely R, Chandler P, Dyson J, Picard JK, Edwards A, et al. Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A beta-chain or normal I-E alpha-chain. Nature 1990; 345: 727–729
   PubMed Web of Science ®Google Scholar
• Bohme J, Schuhbaur B, Kanagawa O, Benoist C, Mathis D. MHC-linked protection from diabetes dissociated from clonal deletion of T cells. Science 1990; 249: 293–295
   PubMed Web of Science ®Google Scholar
• O'Shea H, Yousaf N, Altmann D, Fehervari Z, Tonks P, Hetherington C, Harach S, Bland C, Cooke A, Lund T. Effect of X- and Y-box deletions on the development of diabetes in H-2Ealpha-chain transgenic nonobese diabetic mice. Scand J Immunol 2006; 63: 17–25
   PubMed Web of Science ®Google Scholar
• Trembleau S, Gregori S, Penna G, Gorny I, Adorini L. IL-12 administration reveals diabetogenic T cells in genetically resistant I-Ealpha-transgenic nonobese diabetic mice: Resistance to autoimmune diabetes is associated with binding of Ealpha-derived peptides to the I-A(g7) molecule. J Immunol 2001; 167: 4104–4114
   PubMed Web of Science ®Google Scholar
• Reich EP, Sherwin RS, Kanagawa O, Janeway CA, Jr. An explanation for the protective effect of the MHC class II I-E molecule in murine diabetes. Nature 1989; 341: 326–328
   PubMed Web of Science ®Google Scholar
• Kappler JW, Roehm N, Marrack P. T cell tolerance by clonal elimination in the thymus. Cell 1987; 49: 273–280
   PubMed Web of Science ®Google Scholar
• Nakano N, Kikutani H, Nishimoto H, Kishimoto T. T cell receptor V gene usage of islet beta cell-reactive T cells is not restricted in non-obese diabetic mice. J Exp Med 1991; 173: 1091–1097
   PubMed Web of Science ®Google Scholar
• Tomonari K. Linkage between Tcrb-V and a gene responsible for deletion of Tcrb-V11+T cells. Immunogenetics 1990; 32: 60–62
   PubMed Web of Science ®Google Scholar
• Schmidt D, Verdaguer J, Averill N, Santamaria P. A mechanism for the major histocompatibility complex-linked resistance to autoimmunity. J Exp Med 1997; 186: 1059–1075
   Google Scholar
• Schmidt D, Amrani A, Verdaguer J, Bou S, Santamaria P. Autoantigen-independent deletion of diabetogenic CD4+ thymocytes by protective MHC class II molecules. J Immunol 1999; 162: 4627–4636
   PubMed Web of Science ®Google Scholar
• Parish NM, Chandler P, Quartey-Papafio R, Simpson E, Cooke A. The effect of bone marrow and thymus chimerism between non-obese diabetic (NOD) and NOD-E transgenic mice, on the expression and prevention of diabetes. Eur J Immunol 1993; 23: 2667–2675
   PubMed Web of Science ®Google Scholar
• Hanson MS, Cetkovic-Cvrlje M, Ramiya VK, Atkinson MA, Maclaren NK, Singh B, Elliott JF, Serreze DV, Leiter EH. Quantitative thresholds of MHC class II I-E expressed on hemopoietically derived antigen-presenting cells in transgenic NOD/Lt mice determine level of diabetes resistance and indicate mechanism of protection. J Immunol 1996; 157: 1279–1287
   PubMed Web of Science ®Google Scholar
• Brenden N, Bohme J. Disease-protected major histocompatibility complex Ea-transgenic non-obese diabetic (NOD) mice show interleukin-4 production not seen in susceptible Ea-transgenic and non-transgenic NOD mice. Immunology 1998; 95: 1–7
   PubMed Web of Science ®Google Scholar
• Johnson EA, Silveira P, Chapman HD, Leiter EH, Serreze DV. Inhibition of autoimmune diabetes in nonobese diabetic mice by transgenic restoration of H2-E MHC class II expression: Additive, but unequal, involvement of multiple APC subtypes. J Immunol 2001; 167: 2404–2410
   PubMed Web of Science ®Google Scholar
• Deng H, Apple R, Clare-Salzler M, Trembleau S, Mathis D, Adorini L, Sercarz E. Determinant capture as a possible mechanism of protection afforded by major histocompatibility complex class II molecules in autoimmune disease. J Exp Med 1993; 178: 1675–1680
   PubMed Web of Science ®Google Scholar
• Gregori S, Trembleau S, Penna G, Gallazzi F, Hammer J, Papadopoulos GK, Adorini L. A peptide binding motif for I-Eg7, the MHC class II molecule that protects E alpha-transgenic nonobese diabetic mice from autoimmune diabetes. J Immunol 1999; 162: 6630–6640
   PubMed Web of Science ®Google Scholar
• Nepom GT. A unified hypothesis for the complex genetics of HLA associations with IDDM. Diabetes 1990; 39: 1153–1157
   PubMed Web of Science ®Google Scholar
• Roberts SA, Barbour G, Matarrese MR, Mason DL, Leiter EH, Haskins K, Hanson MS. Adoptive transfer of islet antigen-autoreactive T cell clones to transgenic NOD.Ea(d)mice induces diabetes indicating a lack of I-E mediated protection against activated effector T cells. J Autoimmun 2003; 21: 139–147
   PubMed Web of Science ®Google Scholar
• Forsyth IA, Hutchings A, Butcher GW. A panel of monoclonal antibodies to ovine placental lactogen. J Endocrinol 2000; 165: 435–442
   PubMed Web of Science ®Google Scholar
• Judkowski V, Pinilla C, Schroder K, Tucker L, Sarvetnick N, Wilson DB. Identification of MHC class II-restricted peptide ligands, including a glutamic acid decarboxylase 65 sequence, that stimulate diabetogenic T cells from transgenic BDC2.5 nonobese diabetic mice. J Immunol 2001; 166: 908–917
   PubMed Web of Science ®Google Scholar
• Mellanby RJ, Thomas D, Phillips JM, Cooke A. Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4(+) CD25(+) Foxp3(+) regulatory T cells. Immunology 2007; 121: 15–28
   PubMed Web of Science ®Google Scholar